Aleniglipron
ACCESS II
Gasherbrum Bio, Inc · Phase 2 · Completed · Enrollment 85
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Sentinel | n/r | n/r | n/r | n/r | n/r |
| Cohort 1a | n/r | n/r | n/r | n/r | n/r |
| Cohort 1b | n/r | n/r | n/r | n/r | n/r |
| Cohort 1c | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.